A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61P 25/28 (2006.01) C07K 14/705 (2006.01)
Patent
CA 2755948
A pharmaceutical formulation and method of treatment of prion disease include a RAP agent with a pharmaceuti-cally acceptable carrier and/or excipient, and the administration of same to a subject suffering from or at risk of a prion disease. The RAP agent is an effective means for the prevention and/or treatment of various prion diseases regardless whether the disease is acquired by infection or by genetic mutation.
La présente invention concerne une formulation pharmaceutique et un procédé de traitement de maladie à prion comportant un agent de la protéine associée au récepteur (RAP) avec un support et/ou excipient pharmaceutiquement acceptable, et l'administration de ladite formulation pharmaceutique au sujet atteint ou à risque d'une maladie à prion. L'agent de protéine RAP est un moyen efficace pour la prévention et/ou le traitement de diverses maladies à prion indépendamment du fait que la maladie soit contractée par infection ou mutation génétique.
Cervenakova Larisa
Yakovleva Oksana
American National Red Cross
Torys Llp
LandOfFree
Inhibition of prion protein propagation by receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of prion protein propagation by receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of prion protein propagation by receptor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1787650